Kairos Pharma KAPA
NYSE KAPA
$0.56 -0.02 (-2.97%)
As of: Oct 22, 2026 · 12:10 PM EDT

Kairos Pharma (KAPA) Other Non-Current Assets (2023 - 2025)

Updated

Kairos Pharma (KAPA) reported Other Non-Current Assets of $1.09 million for Q4 2025, down 20.8% from $1.38 million a year earlier.

Analysis

Kairos Pharma (KAPA) Other Non-Current Assets (2023 - 2025) Analysis & Trends

Dating back to Q4 2023, Kairos Pharma's Other Non-Current Assets record includes 5 quarters.

  • By year, Other Non-Current Assets came in at $1.38 million in FY2024 (+185.7%) and $482,000 in FY2023.
  • The Q4 2025 figure ranks as the lowest quarterly Other Non-Current Assets since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,165.06 Bn 1,133.65 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 643.87 Bn 563.73 Bn 17.30 Bn 15.10 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 10.73 Bn
4 Merck 357.68 Bn 312.06 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 301.88 Bn 265.87 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn -
7 Amgen 241.08 Bn 196.48 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 192.57 Bn 166.76 Bn 6.22 Bn 4.75 Bn
9 Pfizer 171.48 Bn 118.13 Bn 10.94 Bn 9.94 Bn
10 Kairos Pharma 10.31 Mn -2.10 Mn - 1.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.09 Mn
Jun 30, 2025 1.69 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 1.38 Mn
Dec 31, 2023 482,000.00
API Access

Kairos Pharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KAPA&period=max&api_key=YOUR_API_KEY